Skip to content
Open access

Evaluating the Low-Density Lipoprotein Cholesterol Paradox in Heart Failure With Reduced Ejection Fraction.

Nov 2026 · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · pp. e048202 · 0 citations
Medicine

Abstract

Background

Hypercholesterolemia is an established cardiovascular risk factor. However, studies in patients with heart failure with reduced ejection fraction (HFrEF) showed an association between low low-density lipoprotein cholesterol (LDL-C) and increased mortality, termed the "LDL-C paradox." This study examined the impact of LDL-C on clinical outcomes in patients with HFrEF and identify distinct hypocholesterolemia subgroups using latent class analysis.

Methods

Consecutive patients with HFrEF (left ventricular EF <40%) from national registries (2016-2022) were stratified by LDL-C quartiles, with the lowest quartile ≤1.73 mmol/L. Latent class analysis was performed to identify subsets of patients in the lowest quartile. Outcomes included 1-year all-cause mortality, cardiovascular mortality, readmission, and composite end points.

Results

Among 2188 patients, the lowest LDL-C quartile had higher 1-year all-cause mortality than Quartile 2 and 3 (P<0.05) but not Quartile 4, with no intergroup differences in cardiovascular mortality, readmissions, or composite outcomes between groups. Latent class analysis identified 2 hypocholesterolemia subgroups: pathological and nonpathological hypocholesterolemia. The pathological subgroup was older, lower weight, with higher comorbidity burden. Compared with patients with hypercholesterolemia, the pathological hypocholesterolemia subgroup had higher 1-year all-cause mortality (adjusted hazard ratio [HR], 2.14 [95% CI, 1.17-2.69], P<0.001), cardiovascular mortality (adjusted HR, 1.93 [95% CI, 1.46-2.54], P<0.001), and composite end points (adjusted HR, 1.15 [95% CI, 1.01-1.30], P=0.037), and the subgroup with nonpathological hypocholesterolemia showed comparable outcomes.

Conclusions

A distinct subset of patients with HFrEF with low LDL-C demonstrates different clinical characteristics (older and higher comorbidity burden) and poorer outcomes, potentially elucidating the "LDL-C paradox" cause in patients with HFrEF.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.